fbpx

Scroll down for references for this edition

PASSWORD:  Diabetes Management Journal is a medical journal exclusively for healthcare professionals. Apply for access here:

DMJ Access Application
Image

Diabetes Management Journal November 2024 References

NEWS & VIEWS REFERENCES

From the Ed’s desk

  1. Owen KB, Foley BC, Smith BJ, Manera KE, Corbett L, Lim M, et al. Sport Participation for Academic Success: Evidence From the Longitudinal Study of Australian Children. Journal of Physical Activity and Health [Internet]. 2023 Dec 23;-1(aop):1–9. Available from: https://journals.humankinetics.com/view/journals/jpah/aop/article-10.1123-jpah.2023-0506/article-10.1123-jpah.2023-0506.xml
  2. Queensland TU of, Lucia ABS, Gatton Q 4072 +61 7 3365 1111 OCU, Maps UH, Queensland D © 2023 TU of. Sporty Aussie kids kick goals for mental health [Internet]. UQ News. Available from: https://www.uq.edu.au/news/article/2023/08/sporty-aussie-kids-kick-goals-mental-health
  3. Rosa CC, Tebar WR, Oliveira CBS, Farah BQ, Casonatto J, Saraiva BTC, et al. Effect of Different Sports Practice on Sleep Quality and Quality of Life in Children and Adolescents: Randomized Clinical Trial. Sports Medicine - Open. 2021 Nov 17;7(1).
  4. Siri Rosenkilde, Sofie Have Hoffmann, Anne Bonde Thorsted, Trine Allerslev Horsbøl, Katrine Rich Madsen, Sara Fokdal Lehn, et al. Loneliness and the risk of type 2 diabetes. BMJ open diabetes research and care. 2024 Mar 1;12(2):e003934–4.
  5. Rafnsson S.B., Orrell M., D’Orsi E., Hogervorst E., Steptoe A. Loneliness, Social Integration, and Incident Dementia Over 6 Years: Prospective Findings From the English Longitudinal Study of Ageing. J. Gerontol. B Psychol. Sci. Soc. Sci. 2020;75:114–124. doi: 10.1093/geronb/gbx087. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

Are we a step closer to insulin-free T1D management?

  1. Danijela Tatovic, Marwaha A, Taylor P, Hanna SJ, Carter K, Cheung WY, et al. Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Nature Medicine [Internet]. 2024 Jul 30 [cited 2024 Aug 26]; Available from: https://pubmed.ncbi.nlm.nih.gov/39079992/
  2. Ouyang W, Kolls JK, Zheng Y. The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation. Immunity [Internet]. 2008 Apr [cited 2019 Mar 30];28(4):454–67. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424508/
  3. Quinn L, Swaby R, Tatovic D, Narendan P, Besser R, Dayan C. What does the licensing of teplizumab mean for diabetes care? Diabetes, Obesity and Metabolism. 2023 Mar 30 

T1D reversed with stem cell transplantation

  1. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell [Internet]. 2024 Sep 25 [cited 2024 Sep 26]; Available from: https://www.sciencedirect.com/science/article/pii/S0092867424010225?via%3Dihub
  2. Wu J, Li T, Guo M, Ji J, Meng X, Fu T, et al. Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue. Cell Discovery [Internet]. 2024 Apr 30 [cited 2024 May 15];10(1):1–5. Available from: https://www.nature.com/articles/s41421-024-00662-3
  3. Mallapaty S. Stem cells reverse woman’s diabetes — a world first. Nature [Internet]. 2024 Sep 26; Available from: https://www.nature.com/articles/d41586-024-03129-3

Smart Insulin - glucose-responsive

  1. Monash researchers set to develop new insulin formulation which could transform type 1 diabetes management [Internet]. Medicine, Nursing and Health Sciences. 2024 [cited 2024 Oct 3]. Available from: https://www.monash.edu/medicine/news/latest/2024-articles/monash-researchers-set-to-develop-new-insulin-formulation-which-could-transform-type-1-diabetes-management
  2. Xu R, Bhangu SK, Sourris KC, Vanni D, Sani MA, Karas JA, et al. An Engineered Nanosugar Enables Rapid and Sustained Glucose-Responsive Insulin Delivery in Diabetic Mice. Advanced Materials (Deerfield Beach, Fla) [Internet]. 2023 May 1;35(21):e2210392. Available from: https://pubmed.ncbi.nlm.nih.gov/36908046/
  3. Gregory A. Scientists hail “smart” insulin that responds to changing blood sugar levels in real time [Internet]. the Guardian. The Guardian; 2024. Available from: https://www.theguardian.com/society/article/2024/

FEATURE REFERENCES

p6-9 Aligning consensus statements: A Harmonised Guide for the Classification and Glycaemic Treatment of T1D, T2D & LADA

  1. “Type 1 Diabetes Index.” Type 1 Diabetes Index, www.t1dindex.org/.
  2. Shields, B. M., et al. “Maturity-Onset Diabetes of the Young (MODY): How Many Cases Are We Missing?” Diabetologia, vol. 53, no. 12, 25 May 2010, pp. 2504–2508, link.springer.com/article/10.1007/s00125-010-1799-4, https://doi.org/10.1007/s00125-010-1799-4. Accessed 27 Nov.
  3. Landin-Olsson, Mona. “Latent autoimmune diabetes in adults.” Annals of the New York Academy of Sciences vol. 958 (2002): 112-6. doi:10.1111/j.1749-6632.2002.tb02953.x
  4. Australian Institute of Health and Welfare. “Diabetes, Deaths from Diabetes - Australian Institute of Health and Welfare.” Australian Institute of Health and Welfare, 2019, www.aihw.gov.au/reports/diabetes/diabetes/contents/deaths-from-diabetes.
  5. Pieralice, Silvia, and Paolo Pozzilli. “Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management.” Diabetes & Metabolism Journal, vol. 42, no. 6, 1 Dec. 2018, pp. 451–464, www.ncbi.nlm.nih.gov/pmc/articles/PMC6300440/, https://doi.org/10.4093/dmj.2018.019.
  6. Buse, John B., et al. “2019 Update To: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).” Diabetes Care, vol. 43, no. 2, 19 Dec. 2020, pp. 487–493, https://doi.org/10.2337/dci19-0066.
  7. Buzzetti, Raffaella, et al. “Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement from an International Expert Panel.” Diabetes, vol. 69, no. 10, 1 Oct. 2020, pp. 2037–2047, diabetes.diabetesjournals.org/content/69/10/2037, https://doi.org/10.2337/dbi20-0017.
  8. Holt, Richard I. G., et al. “The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).” Diabetologia, vol. 64, no. 12, 30 Sept. 2021, https://doi.org/10.1007/s00125-021-05568-3.
  9. Phillip M, Achenbach P, et al. “Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.” Diabetes Care, vol. 47, no. 8, 1 Aug. 2024, pp. 1276-1298, https://doi.org/10.2337/dci24-0042.

p10-12 Diabetes care for Aboriginal & Torres Strait Islander people

  1. Morley S. What works in effective Indigenous community-managed programs and organisations. 2015. CFCA PAPER NO. 32. Available at https://aifs.gov.au/resources/policy-and-practice-papers/what-works-effective-indigenous-community-managed-programs-and [Accessed Sep 22 2024]
  2. Pearson O, Schwartzkopff K, Dawson, A, Hagger A, Karagi A, Davy C, Brown A, Braunack-Mayer A. Aboriginal community controlled health organisations address health equity through action on the social determinants of health of Aboriginal and Torres Strait Islander peoples in Australia. BMC Public Health. 2020. 20 (1859).
  3. Diffey L & Janis A. Decolonizing Diabetes: The Importance of an Antiracist and Anticolonial Lens in Indigenous Health. Can J Diabetes. 2023. 47(5): p 379-380. doi: 10.1016/j.jcjd.2023.05.008.
  4. National Aboriginal Community Controlled Health Organisation. National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people. 2018. Third edition. Canberra, ACT.
  5. Central Australian Rural Practitioners’ Association (CARPA) (2024). CARPA Manuals. CARPA. Alice Springs, NT. Available at: https://remotephcmanuals.com.au/ [Accessed September 22 2024]
  6. Weaver E, Freeman N, Mack S, Titmuss A, Dowler J, Corpus S, et al. I Don't Really Know What Diabetes Is": A Qualitative Study Exploring the Experiences of Aboriginal and Torres Strait Islander Young People Aged 10 to 25 Years Living With Type 2 Diabetes in Northern and Central Australia. 2022. Can J Diabetes. doi: 10.1016/j.jcjd.2022.04.010
  7. Sinclair C, A. Stokes A, Jeffries-Stokes C &Daly J. Positive community responses to an arts-health program designed to tackle diabetes and kidney disease in remote Aboriginal communities in Australia: a qualitative study. Aust N Z J Public Health 2016 40(4): p 307-12. doi: 10.1111/1753-6405.12522.
  8. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020.
  9. Sinclaire, M., Lavallee, B., Cyr, M. & Schultz, A. Indigenous Peoples and Type 2 Diabetes: A Discussion of Colonial Wounds and Epistemic Racism Can J Diabetes 2023 47(5):451-454. doi: 10.1016/j.jcjd.2023.01.008
  10. Kshatriya M, Wang KW, Hildebrand J, Crawford R, Nadarajah A, Youssef M, Rivas A, Kaushal A, Banfield LE, Thabane L, Samaan MC. The Effectiveness of Indigenous Knowledge-Based Lifestyle Interventions in Preventing Obesity and Type 2 Diabetes Mellitus in Indigenous Children in Canada: A Systematic Review. Adolesc Health Med Ther. 2023 Sep 28;14:175-193. doi: 10.2147/AHMT.S405814.

p17-19 Sarcopenic obesity: What it is, why it is important and how we manage it

  1. Fan S, Cai Y, Wei Y, Yang J, Gao J, Yang Y. Sarcopenic obesity and osteoporosis: Research progress and hot spots. Exp Gerontol. 2024;195:112544.
  2. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, Frara S, Frühbeck G, Genton L, Gepner Y, Giustina A, Gonzalez MC, Han H-S, Heymsfield SB, Higashiguchi T, Laviano A, Lenzi A, Nyulasi I, Parrinello E, Poggiogalle E, Prado CM, Salvador J, Rolland Y, Santini F, Serlie MJ, Shi H, Sieber CC, Siervo M, Vettor R, Villareal DT, Volkert D, Yu J, Zamboni M, Barazzoni R. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr. 2022;41(4):990-1000.
  3. Palmer AK, Jensen MD. Metabolic changes in aging humans: current evidence and therapeutic strategies. The Journal of Clinical Investigation. 2022;132(16).
  4. Perry BD, Caldow MK, Brennan-Speranza TC, Sbaraglia M, Jerums G, Garnham A, Wong C, Levinger P, Asrar Ul Haq M, Hare DL, Price SR, Levinger I. Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exerc Immunol Rev. 2016;22:94-109.
  5. Merz KE, Thurmond DC. Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake. Compr Physiol. 2020;10(3):785-809.
  6. O'Neill HM. AMPK and Exercise: Glucose Uptake and Insulin Sensitivity. Diabetes Metab J. 2013;37(1):1-21.
  7. Perdomo CM, Cohen RV, Sumithran P, Clément K, Frühbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401(10382):1116-30.
  8. Hurtado MD, Saadedine M, Kapoor E, Shufelt CL, Faubion SS. Weight Gain in Midlife Women. Curr Obes Rep. 2024;13(2):352-63.
  9. Mehta JM, Manson JE. The menopausal transition period and cardiovascular risk. Nat Rev Cardiol. 2024;21(3):203-11.
  10. Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster JY, Bruyère O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E, Kaufman JM, Landi F, Laslop A, Locquet M, Maggi S, McCloskey E, Perna S, Rizzoli R, Rolland Y, Rondanelli M, Szulc P, Vellas B, Vlaskovska M, Cooper C. Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review. Calcif Tissue Int. 2019;105(2):109-24.
  11. Peng TC, Chen WL, Chen YY, Chao YP, Wu LW, Kao TW. Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan. Br J Nutr. 2021;126(11):1749-57.
  12. Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, Ma B. Global prevalence of sarcopenic obesity in older adults: A systematic review and meta-analysis. Clin Nutr. 2021;40(7):4633-41.
  13. Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531-2.
  14. Sergi G, De Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, Bano G, Coin A, Manzato E, Perissinotto E. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr. 2015;34(4):667-73.
  15. Prado CM, Batsis JA, Donini LM, Gonzalez MC, Siervo M. Sarcopenic obesity in older adults: a clinical overview. Nature Reviews Endocrinology. 2024;20(5):261-77.
  16. Horn DB, Almandoz JP, Look M. What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review. Postgrad Med. 2022;134(4):359-75.
  17. Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes (Lond). 2015;39(8):1188-96.
  18. Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity Management in Adults: A Review. JAMA. 2023;330(20):2000-15.
  19. El Ansari W, Elhag W. Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps—a Scoping Review. Obes Surg. 2021;31(4):1755-66.
  20. Felsenreich DM, Langer FB, Kefurt R, Panhofer P, Schermann M, Beckerhinn P, Sperker C, Prager G. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(9):1655-62.
  21. Sayadi Shahraki M, Mahmoudieh M, Kalidari B, Melali H, Mousavi M, Ghourban Abadi MR, Mirhosseini SH, Mirhosseini Dehabadi SA. Bone Health after Bariatric Surgery: Consequences, Prevention, and Treatment. Adv Biomed Res. 2022;11:92.
  22. Aragon AA, Tipton KD, Schoenfeld BJ. Age-related muscle anabolic resistance: inevitable or preventable? Nutr Rev. 2022;81(4):441-54.
  23. Balachandran AT, Steele J, Angielczyk D, Belio M, Schoenfeld BJ, Quiles N, Askin N, Abou-Setta AM. Comparison of power training vs traditional strength training on physical function in older adults: a systematic review and meta-analysis. JAMA network open. 2022;5(5):e2211623-e.
  24. Allen MD, Dalton BH, Gilmore KJ, McNeil CJ, Doherty TJ, Rice CL, Power GA. Neuroprotective effects of exercise on the aging human neuromuscular system. Experimental Gerontology. 2021;152:111465.
  25. Chen HT, Chung YC, Chen YJ, Ho SY, Wu HJ. Effects of different types of exercise on body composition, muscle strength, and IGF‐1 in the elderly with sarcopenic obesity. Journal of the American Geriatrics Society. 2017;65(4):827-32.
  26. Society AG. Guideline for the prevention of falls in older persons. J Am Geriatr Soc. 2001;49:664-72.
  27. Robertson MC, Campbell AJ, Gardner MM, Devlin N. Preventing injuries in older people by preventing falls: A meta‐analysis of individual‐level data. Journal of the American geriatrics society. 2002;50(5):905-11.
  28. Trouwborst I, Verreijen A, Memelink R, Massanet P, Boirie Y, Weijs P, Tieland M. Exercise and nutrition strategies to counteract sarcopenic obesity. Nutrients. 2018;10(5):605.
  29. Parr EB, Coffey VG, Hawley JA. ‘Sarcobesity’: a metabolic conundrum. Maturitas. 2013;74(2):109-13.
  30. Foster‐Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A, Bain CE, Wang CY, Blackburn GL, McTiernan A. Effect of diet and exercise, alone or combined, on weight and body composition in overweight‐to‐obese postmenopausal women. Obesity. 2012;20(8):1628-38.
  31. Chaston TB, Dixon J, O'Brien PE. Changes in fat-free mass during significant weight loss: a systematic review. International journal of obesity. 2007;31(5):743-50.
  32. Robinson S, Cooper C, Sayer AA. Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies. Clinical Nutrition and Aging. 2017:3-18.
  33. Yin Y-H, Liu JYW, Välimäki M. Effectiveness of non-pharmacological interventions on the management of sarcopenic obesity: A systematic review and meta-analysis. Experimental gerontology. 2020;135:110937.
  34. Perry CA, Van Guilder GP, Butterick TA. Decreased myostatin in response to a controlled DASH diet is associated with improved body composition and cardiometabolic biomarkers in older adults: Results from a controlled-feeding diet intervention study. BMC nutrition. 2022;8(1):24.
  35. Bhasin S, Krishnan V, Storer TW, Steiner M, Dobs AS. Androgens and selective androgen receptor modulators to treat functional limitations associated with aging and chronic disease. The Journals of Gerontology: Series A. 2023;78(Supplement_1):25-31.

p20-23 Advancing diabetes management – the role of AI

  1. Roy A. Artificial intelligence: 10 promising interventions for healthcare [Internet]. NIHR Evidence. 2023. Available from: https://evidence.nihr.ac.uk/collection/artificial-intelligence-10-promising-interventions-for-healthcare/
  2. Khorraminezhad, L., et al., Dairy product intake modifies gut microbiota composition among hyperinsulinemic individuals. Eur J Nutr, 2021. 60(1): p. 159-167.
  3. Liu, Y., et al., Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention. Cell Metab, 2020. 31(1): p. 77-91.e5.
  4. Guan, Z., et al., Artificial intelligence in diabetes management: Advancements, opportunities, and challenges. Cell Reports Medicine, 2023.
  5. Oikonomou, E.K., et al., Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes. Diabetes Care, 2022. 45(4): p. 965-974.
  6. Zhang, P., et al., Using Momentary Assessment and Machine Learning to Identify Barriers to Self-management in Type 1 Diabetes: Observational Study. JMIR Mhealth Uhealth, 2022. 10(3): p. e21959.
  7. Han, X., J. Tan, and Y. He, Deep Learning Algorithm-Based MRI Image in the Diagnosis of Diabetic Macular Edema. Contrast Media Mol Imaging, 2022. 2022: p. 1035619.
  8. Roberts, P.K., et al., Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Ophthalmol, 2020. 138(9): p. 945-953.
  9. Guan H, Wang Y, Niu P, Zhang Y, Zhang Y, Miao R, et al. The role of machine learning in advancing diabetic foot: a review. Frontiers in endocrinology. 2024 Apr 29;15.
  10. Liang X, Du M, Chen Z. Artificial intelligence-aided ultrasound in renal diseases: a systematic review. Quantitative imaging in medicine and surgery [Internet]. 2023 Jun 1 [cited 2023 Sep 22];13(6):3988–4001. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240007/
  11. Gala, D., et al. The role of artificial intelligence in improving patient outcomes and future of healthcare delivery in cardiology: a narrative review of the literature. in Healthcare. 2024. MDPI.
  12. Khalifa, M. and M. Albadawy, AI in diagnostic imaging: Revolutionising accuracy and efficiency. Computer Methods and Programs in Biomedicine Update, 2024: p. 100146.
  13. Mohsen, F., et al., A scoping review of artificial intelligence-based methods for diabetes risk prediction. NPJ Digital Medicine, 2023. 6(1): p. 197.
  14. Diabetes care and AI: a looming threat or a necessary advancement? The Lancet Diabetes & endocrinology. 2023 Jul 1;11(7):441–1.\
  15. Hu W, Joseph S, Li R, Woods E, Sun J, Shen M, et al. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis. EClinicalMedicine (Oxford). 2024 Jan 1;67:102387–7.
  16. Medanki, S., et al., Artificial intelligence powered glucose monitoring and controlling system: Pumping module. World Journal of Experimental Medicine, 2024. 14(1).
  17. Fabbrizio, A., et al. Smart devices for health and wellness applied to tele-exercise: an overview of new trends and technologies such as IoT and AI. in Healthcare. 2023. MDPI.
  18. Federspiel F, Mitchell R, Asokan A, Umana C, McCoy D. Threats by Artificial Intelligence to Human Health and Human Existence. BMJ Global Health [Internet]. 2023 May;8(5):e010435. Available from: https://gh.bmj.com/content/8/5/e010435
  19. Goods T. Artificial Intelligence (AI) and medical device software [Internet]. Therapeutic Goods Administration (TGA). 2024. Available from: https://www.tga.gov.au/how-we-regulate/manufacturing/manufacture-medical-device/manufacture-specific-types-medical-devices/artificial-intelligence-ai-and-medical-device-software
  20. HITRUST. The Ethics of AI in Healthcare [Internet]. hitrustalliance.net. 2023. Available from: https://hitrustalliance.net/blog/the-ethics-of-ai-in-healthcare

p24-26 Ultra-processed foods & T2D

  1. Monteiro CA. Nutrition and health. The issue is not food, nor nutrients, so much as processing. Public Health Nutrition. 2009;12(5):729-31.
  2. Monteiro CA, Cannon G, Lawrence M, Costa Louzada ML, Machado PP. Ultra-processed foods, diet quality, and health using the NOVA classification system. Rome: FAO; 2019.
  3. Barrett EM, Gaines A, Coyle DH, Pettigrew S, Shahid M, Maganja D, Jones A, Rayner M, Mozaffarian D, Taylor F, Ghammachi N, Wu JHY. Comparing product healthiness according to the Health Star Rating and the NOVA classification system and implications for food labelling systems: An analysis of 25 486 products in Australia. Nutr Bull. 2023.
  4. Machado P, Steele E, Levy R. Ultra-processed foods and recommended intake levels of nutrients linked to non-communicable diseases in Australia: evidence from a nationally representative crosssectional study. BMJ Open. 2019;9.
  5. Coyle DH, Huang L, Shahid M, Gaines A, Di Tanna GL, Louie JCY, Pan X, Marklund M, Neal B, Wu JHY. Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel. International Journal of Behavioral Nutrition and Physical Activity. 2022;19(1):148.
  6. Almarshad MI, Algonaiman R, Alharbi HF, Almujaydil MS, Barakat H. Relationship between ultra-processed food consumption and risk of diabetes mellitus: a mini-review. Nutrients. 2022;14(12):2366.
  7. Levy RB, Rauber F, Chang K, Louzada MLdC, Monteiro CA, Millett C, Vamos EP. Ultra-processed food consumption and type 2 diabetes incidence: a prospective cohort study. Clinical Nutrition. 2021;40(5):3608-14.
  8. Duan M-J, Vinke PC, Navis G, Corpeleijn E, Dekker LH. Ultra-processed food and incident type 2 diabetes: studying the underlying consumption patterns to unravel the health effects of this heterogeneous food category in the prospective Lifelines cohort. BMC medicine. 2022;20:1-11.
  9. Srour B, Fezeu LK, Kesse-Guyot E, Allès B, Debras C, Druesne-Pecollo N, Chazelas E, Deschasaux M, Hercberg S, Galan P. Ultraprocessed food consumption and risk of type 2 diabetes among participants of the NutriNet-Santé prospective cohort. JAMA internal medicine. 2020;180(2):283-91.
  10. Nardocci M, Polsky JY, Moubarac J-C. Consumption of ultra-processed foods is associated with obesity, diabetes and hypertension in Canadian adults. Canadian journal of public health. 2021;112:421-9.
  11. Moradi S, Hojjati Kermani Ma, Bagheri R, Mohammadi H, Jayedi A, Lane MM, Asbaghi O, Mehrabani S, Suzuki K. Ultra-processed food consumption and adult diabetes risk: a systematic review and dose-response meta-analysis. Nutrients. 2021;13(12):4410.
  12. Lane MM, Gamage E, Du S, Ashtree DN, McGuinness AJ, Gauci S, Baker P, Lawrence M, Rebholz CM, Srour B, Touvier M, Jacka FN, O’Neil A, Segasby T, Marx W. Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ. 2024;384:e077310.
  13. Schönenberger KA, Huwiler VV, Reber E, Mühlebach S, Stanga Z, Pestoni G, Faeh D. Dietary fibre intake and its association with ultraprocessed food consumption in the general population of Switzerland: analysis of a population-based, cross-sectional national nutrition survey. BMJ Nutrition, Prevention & Health. 2024:e000727.
  14. Llavero-Valero M, Escalada-San Martín J, Martínez-González MA, Basterra-Gortari FJ, de la Fuente-Arrillaga C, Bes-Rastrollo M. Ultra-processed foods and type-2 diabetes risk in the SUN project: A prospective cohort study. Clinical Nutrition. 2021;40(5):2817-24.
  15. Martínez Steele E, Khandpur N, da Costa Louzada ML, Monteiro CA. Association between dietary contribution of ultra-processed foods and urinary concentrations of phthalates and bisphenol in a nationally representative sample of the US population aged 6 years and older. PloS one. 2020;15(7):e0236738.
  16. Fardet A. Minimally processed foods are more satiating and less hyperglycemic than ultra-processed foods: a preliminary study with 98 ready-to-eat foods. Food Funct. 2016;7(5):2338-46.
  17. DiNicolantonio JJ, O'Keefe JH, Lucan SC, editors. Added fructose: a principal driver of type 2 diabetes mellitus and its consequences. Mayo Clinic Proceedings; 2015: Elsevier.
  18. Lanaspa MA, Kuwabara M, Andres-Hernando A, Li N, Cicerchi C, Jensen T, Orlicky DJ, Roncal-Jimenez CA, Ishimoto T, Nakagawa T. High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proceedings of the National Academy of Sciences. 2018;115(12):3138-43.
  19. Müller M, Canfora EE, Blaak EE. Gastrointestinal transit time, glucose homeostasis and metabolic health: modulation by dietary fibers. Nutrients. 2018;10(3):275.
  20. Moradi S, Entezari MH, Mohammadi H, Jayedi A, Lazaridi A-V, Kermani MaH, Miraghajani M. Ultra-processed food consumption and adult obesity risk: a systematic review and dose-response meta-analysis. Crit Rev Food Sci Nutr. 2023;63(2):249-60.
  21. Hall KD, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen KY, Chung ST, Costa E, Courville A, Darcey V. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell metabolism. 2019;30(1):67-77. e3.
  22. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes care. 2011;34(7):1481-6.
  23. Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes care. 2019;42(5):731.
  24. Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023;66(6):965-85.
  25. Kolahdouz-Mohammadi R, Soltani S, Clayton ZS, Salehi-Abargouei A. Sodium status is associated with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies. European journal of nutrition. 2021;60:3543-65.
  26. Iizuka K, Yabe D. Dietary and nutritional guidelines for people with diabetes. MDPI; 2023. p. 4314.
  27. Cordova R, Viallon V, Fontvieille E, Peruchet-Noray L, Jansana A, Wagner K-H, Kyrø C, Tjønneland A, Katzke V, Bajracharya R, Schulze MB, Masala G, Sieri S, Panico S, Ricceri F, Tumino R, Boer JMA, Verschuren WMM, van der Schouw YT, Jakszyn P, Redondo-Sánchez D, Amiano P, Huerta JM, Guevara M, Borné Y, Sonestedt E, Tsilidis KK, Millett C, Heath AK, Aglago EK, Aune D, Gunter MJ, Ferrari P, Huybrechts I, Freisling H. Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. The Lancet Regional Health – Europe. 2023;35.
  28. Chen Z, Khandpur N, Desjardins C, Wang L, Monteiro CA, Rossato SL, Fung TT, Manson JE, Willett WC, Rimm EB, Hu FB, Sun Q, Drouin-Chartier J-P. Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies. Diabetes Care. 2023;46(7):1335-44.
  29. National Health and Medical Research Council. Australian Dietary Guidelines Summary Canberra: National Health and Medical Research Council; 2013. https://www.eatforhealth.gov.au/sites/default/files/2022-09/n55a_australian_dietary_guidelines_summary_131014_1.pdf. Accessed 17 June 2024

-- ENDS --